Accumulating evidence indicates that STC1 deregulation is linked to various cancers, including breast cancer [15], hepatocellular carcinoma (HCC) [16], glioblastoma multiforme (GBM) [17], pancreatic ductal adenocarcinoma [18], papillary thyroid carcinoma (PTC) [19], ovarian cancer [20], and gastric cancer [21]. The gene discussed is STC1; the disease is hepatocellular carcinoma.